Basics Caribou Biosciences, Inc. IPO Date: July 23, 2021 Sector: Healthcare Industry: Biotech Market Cap: $174.14M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.73% Avg Daily Range (30 D): $0.07 | 3.68% Avg Daily Range (90 D): $0.07 | 4.49% Institutional Daily Volume Avg Daily Volume: 1.07M Avg Daily Volume (30 D): 1.06M Avg Daily Volume (90 D): 1.19M Trade Size Avg Trade Size (Sh.): 138 Avg Trade Size (Sh.) (30 D): 207 Avg Trade Size (Sh.) (90 D): 238 Institutional Trades Total Inst.Trades: 506 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $3.78M Avg Inst. Trade (90 D): $3.78M Avg Inst. Trade Volume: .28M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.87M Avg Closing Trade (30 D): $9.15M Avg Closing Trade (90 D): $9.15M Avg Closing Volume: 301.18K     News Sep 2, 2025 @ 10:00 AM Gene Editing Market to Surpass USD 15.46 Billion b... Source: Sns Insider Jul 25, 2025 @ 11:35 PM CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Inve... Source: Bragar Eagel & Squire, P.C. May 6, 2025 @ 8:00 PM Caribou Biosciences to Participate in the BofA Sec... Source: N/A Feb 22, 2025 @ 2:19 PM CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSE... Source: N/A Feb 19, 2025 @ 9:00 PM CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.78 $-.58 $-.43 Diluted EPS $-1.78 $-.58 $-.43 Revenue $ 9.12M $ 2.67M $ 2.35M Gross Profit $ $ $ Net Income / Loss $ -164.26M $ -54.1M $ -39.99M Operating Income / Loss $ -167.6M $ -47.58M $ -42.91M Cost of Revenue $ $ $ Net Cash Flow $ -12.67M $ -4.22M $ 13.12M PE Ratio